19 May 2013
Keywords: elan, migraine, drug, nears, approval, frovatriptan, developed
Article | 04 May 2000
Frovatriptan, the migraine drug developed by Vanguard Medica of the UKand licensed to Ireland's Elan, has moved a step closer ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 May 2000
3 May 2000
17 May 2013
© 2013 thepharmaletter.com